Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study

Helicobacter Pylori

Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies

Helicobacter.

Ciccaglione AF, Cellini L, Marzio L

doi: 10.1111/hel.12606.

Helicobacter Pylori

Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial

Helicobacter.

Kakiuchi T, Mizoe A, Yamamoto K, Imamura I, Hashiguchi K, Kawakubo H, Yamaguchi D, Fujioka Y, Nakayama A, Okuda M, Matsuo M

doi: 10.1111/hel.12690.

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains

Aliment Pharmacol Ther.

Gatta L, Scarpignato C, Fiorini G, Belsey J, Saracino IM, Ricci C, Vaira D

doi: 10.1111/apt.14597.

Helicobacter Pylori

Impact of Previous Exposure to Macrolide Antibiotics on Helicobacter pylori Infection Treatment Outcomes

Am J Gastroenterol.

Boltin D, Levi Z, Gingold-Belfer R, Gabay H, Shochat T, Niv Y, Dickman R, Dotan I, Birkenfeld S

doi: 10.14309/ajg.

Helicobacter Pylori

Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori. Two randomized pilot studies

Helicobacter.

Dore MP, Bibbò S, Loria M, Salis R, Manca A, Pes GM, Graham DY

doi: 10.1111/hel.12659.

RECOMMENDED

Helicobacter Pylori

Review: Treatment of Helicobacter pylori Infection 2019

Helicobacter.

O'Connor A, Liou JM, Gisbert JP, O'Morain C

doi: 10.1111/hel.12640.

Helicobacter Pylori

Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota

J Gastroenterol Hepatol.

Liou JM, Lee YC, Wu MS

doi: 10.1111/jgh.14992.

Helicobacter Pylori

Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection

Am J Gastroenterol.

Kumar S, Metz DC, Kaplan DE, Goldberg DS

doi: 10.14309/ajg.0000000000000626.

Celiac DiseaseHelicobacter Pylori

Helicobacter pylori infection in children with celiac disease: Multi-center, cross-sectional study

Helicobacter.

Bayrak NA, Tutar E, Volkan B, Sahin Akkelle B, Polat E, Kutluk G, Ertem D

doi: 10.1111/hel.12691.

Related content

Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies

Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains

Impact of Previous Exposure to Macrolide Antibiotics on Helicobacter pylori Infection Treatment Outcomes

Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori. Two randomized pilot studies

Review: Treatment of Helicobacter pylori Infection 2019

Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota

Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection

Helicobacter pylori infection in children with celiac disease: Multi-center, cross-sectional study